1. OS4.3 The BReMen trial: Patients with benign meningioma - is rehabilitation really necessary?. (19th September 2018) Authors: Kessler, A F; Krause, K; Al-Shameri, B; Weiland, J; Linsenmann, T; Ernestus, R; Hagemann, C; Löhr, M; Jentschke, E Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P01.045 Adherence to Tumor Treating Fields in patients with high-grade glioma - a single center experience. (19th September 2018) Authors: Kessler, A; Weiland, J; Breun, M; Linsenmann, T; Ernestus, R; Hagemann, C; Löhr, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P01.046 Complete radiological response under treatment with Tumor Treating Fields following subtotal resection in a series of three Glioblastoma patients. (19th September 2018) Authors: Kessler, A; Linsenmann, T; Westermaier, T; Wolber, W; Hagemann, C; Ernestus, R; Löhr, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P01.047 Improving quality of life in glioma patients: platform for exchange of patients' expertise in TTFields practice. (19th September 2018) Authors: Kessler, A; Jentschke, E; Weiland, J; Dufner, V; Lilla, N; Linsenmann, T; Westermaier, T; Hagemann, C; Ernestus, R; Löhr, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P01.050 Circulating MACC1 transcript plasma levels in glioblastoma patients segregate together with prognostic markers and treatment response. (19th September 2018) Authors: Hagemann, C; Neuhaus, N; Dahlmann, M; Kessler, A F; Kobelt, D; Herrmann, P; Eyrich, M; Freitag, B; Freitag, B; Linsenmann, T; Monoranu, C M; Ernestus, R; Löhr, M; Stein, U Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P14.28 First report on the combination of axitinib and Tumor Treating Fields (TTFields) in three patients with recurrent glioblastoma. (6th September 2019) Authors: Keßler, A F; Weiland, J; Linsenmann, T; Ernestus, R; Hagemann, C; Löhr, M Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P14.60 FET PET response upon radiochemotherapy followed by Tumor Treating Fields (TTFields) in a patient with progressive high-grade glioma. (6th September 2019) Authors: Keßler, A F; Weiland, J; Linsenmann, T; Ernestus, R; Hagemann, C; Löhr, M Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗